We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
-2.46%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.96B
AUM Growth
-$234M
Cap. Flow
-$704K
Cap. Flow %
-0.01%
Top 10 Hldgs %
20.98%
Holding
251
New
12
Increased
75
Reduced
130
Closed
13

Top Buys

Rank Stock Value
1
IFF icon
International Flavors & Fragrances
IFF
+$12.3M
2
LW icon
Lamb Weston
LW
+$11.1M
3
RXO icon
RXO
RXO
+$10.9M
4
MRNA icon
Moderna
MRNA
+$10.6M
5
ELAN icon
Elanco Animal Health
ELAN
+$10.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.3M
2
XPO icon
XPO
XPO
+$15.3M
3
META icon
Meta Platforms (Facebook)
META
+$8.2M
4
MSFT icon
Microsoft
MSFT
+$7.76M
5
GE icon
GE Aerospace
GE
+$6.48M

Sector Composition

Rank Sector Weight
1 Financials 17.86%
2 Healthcare 15.7%
3 Technology 15.69%
4 Industrials 10.96%
5 Communication Services 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
201
MetLife
MET
$62.1B
$289K ﹤0.01%
4,589
-2,865
-38% -$178K
CF icon
202
CF Industries
CF
$17.3B
$283K ﹤0.01%
+3,304
New +$261K
BN icon
203
Brookfield
BN
$108B
$282K ﹤0.01%
13,539
+150
+1% +$3.38K
AEP icon
204
American Electric Power
AEP
$68.4B
$278K ﹤0.01%
3,699
PGR icon
205
Progressive
PGR
$125B
$276K ﹤0.01%
1,982
+2
+0.1% +$263
ETN icon
206
Eaton
ETN
$174B
$276K ﹤0.01%
+1,292
New +$279K
DOW icon
207
Dow Inc
DOW
$21.2B
$275K ﹤0.01%
5,329
+21
+0.4% +$1.13K
PH icon
208
Parker-Hannifin
PH
$135B
$271K ﹤0.01%
+697
New +$280K
HCA icon
209
HCA Healthcare
HCA
$89.5B
$256K ﹤0.01%
1,040
OTIS icon
210
Otis Worldwide
OTIS
$28.2B
$256K ﹤0.01%
+3,185
New +$272K
AMP icon
211
Ameriprise Financial
AMP
$48.8B
$251K ﹤0.01%
762
+4
+0.5% +$1.36K
GS icon
212
Goldman Sachs
GS
$303B
$248K ﹤0.01%
766
-3
-0.4% -$1K
CP icon
213
Canadian Pacific Kansas City
CP
$80.5B
$241K ﹤0.01%
3,244
+35
+1% +$2.78K
NSC icon
214
Norfolk Southern
NSC
$75.1B
$231K ﹤0.01%
1,174
LMT icon
215
Lockheed Martin
LMT
$136B
$229K ﹤0.01%
559
CTVA icon
216
Corteva
CTVA
$51.3B
$227K ﹤0.01%
4,441
+21
+0.5% +$1.11K
CSX icon
217
CSX Corp
CSX
$93.1B
$225K ﹤0.01%
7,303
-60
-0.8% -$1.9K
GD icon
218
General Dynamics
GD
$106B
$220K ﹤0.01%
997
TJX icon
219
TJX Companies
TJX
$178B
$220K ﹤0.01%
+2,470
New +$217K
ODFL icon
220
Old Dominion Freight Line
ODFL
$44.9B
$213K ﹤0.01%
+1,040
New +$210K
NFLX icon
221
Netflix
NFLX
$309B
$211K ﹤0.01%
5,590
+620
+12% +$26.3K
ZION icon
222
Zions Bancorporation
ZION
$10.3B
$208K ﹤0.01%
+5,970
New +$208K
GILD icon
223
Gilead Sciences
GILD
$165B
$206K ﹤0.01%
2,751
-665
-19% -$51.1K
BLK icon
224
Blackrock
BLK
$176B
$202K ﹤0.01%
313
-33
-10% -$23.1K
PLUG icon
225
Plug Power
PLUG
$3.04B
$175K ﹤0.01%
23,000
-59
-0.3% -$576

Similar funds

Douglas Lane & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Douglas Lane & Associates held 251 positions worth $5.96B, down 3.8% from $6.19B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q3 2023 filing shows 12 new, 75 increased, 130 reduced and 13 closed positions. Its largest new stake was Kenvue: 61,993 shares worth $1.24M. The largest sale was NVIDIA, an estimated $29.3M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Douglas Lane & Associates's largest Q3 2023 buy was Kenvue: 61,993 shares worth $1.24M.
  • Douglas Lane & Associates added most to International Flavors & Fragrances in Q3 2023, an estimated $12.3M increase.
  • Douglas Lane & Associates's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $29.3M.
  • Douglas Lane & Associates fully exited Masco in Q3 2023, selling an estimated $230K.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $5.96B portfolio in Q3 2023.
  • Douglas Lane & Associates opened 12 new positions and closed 13 in Q3 2023.
  • Douglas Lane & Associates's portfolio value fell 3.8% quarter-over-quarter to $5.96B.

Based on Douglas Lane & Associates's 13F filing for Q3 2023, filed 16 Oct 2023.